MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma

Masaki Murata1, Vladimir Bilim1,2, Yuko Shirono1

  • 1Department of Urology, Division of Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.

PubMed

Insights

MicroRNAs regulate glycogen synthase kinase-3β (GSK-3β) in renal cell carcinoma (RCC). While miR-4465 targets GSK-3β, its impact on RCC cell functions is complex, necessitating further research into regulatory networks.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Advanced renal cell carcinoma (RCC) treatment has improved but many patients remain uncured.
  • Glycogen synthase kinase-3β (GSK-3β) inhibition is a potential therapeutic strategy for RCC, but its regulation is not fully understood.
  • MicroRNAs (miRNAs) are key post-translational regulators of gene expression.

Purpose of the Study:

  • To investigate the role of miRNAs in regulating GSK-3β expression in RCC.
  • To identify specific miRNAs that target GSK-3β in renal cancer cells.

Main Methods:

  • Candidate miRNAs targeting GSK-3β were selected from databases.
  • Luciferase assays and Western blot analysis were used to confirm miRNA-target interaction and protein expression changes.
  • Functional assays assessed the impact of miRNA overexpression on RCC cell proliferation, migration, invasion, cell cycle, and apoptosis.

Main Results:

  • hsa-miR-4465 (miR-4465) was found to be downregulated in RCC cell lines and tissues.
  • miR-4465 directly targets the 3' untranslated region of GSK-3β, leading to decreased protein expression.
  • Overexpression of miR-4465 suppressed invasion in A498 and Caki-1 cells, but effects on proliferation and migration were cell-specific, with no impact on cell cycle or apoptosis.

Conclusions:

  • miR-4465 regulates GSK-3β expression in RCC.
  • The functional impact of miR-4465 as a single molecule on RCC cell behavior is not consistent.
  • Further investigation into miRNA regulatory networks is crucial for understanding RCC pathogenesis and developing novel therapies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K